Category: misconduct investigations

A retraction gets retracted — but the first author’s contract is still terminated

After issuing a retraction notice May 30 for a biomedical engineering paper, the journal has since pulled the notice, citing “a potential problem.”

After doing some digging, we’ve learned more about the “potential problem.”

Apparently, the retraction was requested by Nanyang Technological University (NTU) in Singapore. NTU has been investigating the first author for months, after it received an allegation about an unrelated manuscript. As a result, NTU terminated first author Hamidreza Namazi‘s contract as a research fellow earlier this year.

As part of the investigation, NTU began to look at Namazi’s other papers, and discovered several with potential problems — including this one, which NTU believes did not receive proper ethical approvals. So it contacted the journal to raise its concerns.

Namazi, however, told us that he and his colleague obtained approval from another organization, but didn’t make that clear in the paper — so the journal has retracted its retraction notice while it investigates Namazi’s claim.

In place of the original retraction notice, a notice now reads:

Continue reading A retraction gets retracted — but the first author’s contract is still terminated

NIH neuroscientist up to 16 retractions

Stanley Rapoport. Source: NIH

Neuroscientist Stanley Rapoport just can’t catch a break.

Rapoport, who’s based at National Institute on Aging, is continuing to experience fallout from his research collaborations, after multiple co-authors have been found to have committed misconduct.

Most recently, Rapoport has had four papers retracted in three journals, citing falsified data in a range of figures. Although the notices do not specify how the data falsification occurred, Jagadeesh Rao, who was recently found guilty of research misconduct, is corresponding author on all four papers.

Back in December, Rapoport told us that a “number of retractions [for] Rao are still in the works:” Continue reading NIH neuroscientist up to 16 retractions

It’s not just whistleblowers who deserve protection during misconduct investigations, say researchers

Sven Hendrix
Lex Bouter

In 2010, the former PhD supervisor of Sven Hendrix, a neuroanatomist at Hasselt University in Belgium, was accused of misconduct. Although the allegations were eventually dropped, the experience was emotionally and professionally draining – and Hendrix wanted the research community to know about it. In 2015, he shared his story at a conference in Rotterdam; in the audience was Lex Bouter at Vrije Universiteit in Amsterdam, who works on research integrity (and is co-chair of this year’s World Conference on Research Integrity [WCRI], happening now). Bouter invited Hendrix to write a paper with him. This month, Accountability in Research published “Both Whistle Blowers and the Scientists They Accuse are Vulnerable and Deserve Protection,” an abstract of which is being presented today at the WCRI. We spoke with Hendrix and Bouter about their paper.

Retraction Watch: The title of your paper kind of says it all. Can you say more about what prompted you to write it?

Continue reading It’s not just whistleblowers who deserve protection during misconduct investigations, say researchers

When misconduct occurs, how should journals and institutions work together?

Elizabeth Wager

When the World Conference on Research Integrity kicks off at the end of this month, one topic that will be on attendees’ minds is how journals and research institutions should collaborate when investigating the integrity of individual publications. That’s because this week, a group of stakeholders from institutions and the publishing world released draft guidelines on bioRxiv for how this relationship might work, dubbed the Cooperation And Liaison Between Universities And Editors (CLUE) guidelines. We spoke with first author Elizabeth Wager, Publications Consultant at Sideview and a co-Editor-in-Chief at Research Integrity & Peer Review (as well as a member of the board of direcftors of our parent non-profit organization).

Retraction Watch: The Committee on Publication Ethics (COPE) has issued guidelines for how research institutions and journals should cooperate when investigating concerns over research integrity. What do the CLUE guidelines add to that discussion?

Continue reading When misconduct occurs, how should journals and institutions work together?

Denmark to institute sweeping changes in handling misconduct

In six weeks, new policies for handling misconduct in Denmark will go into effect, which alter the definition of misconduct and establish clear policies for who handles such allegations.

Starting July 1, research misconduct will be limited to how it’s typically defined elsewhere — fabrication, falsification, and plagiarism (the previous definition included serious breaches of good scientific practices). All such allegations will be investigated by a central body, The Board for the Prevention of Scientific Misconduct — not at the institutions where the allegations are focused, as it has been in the past. Institutions, however, will remain responsible for investigating allegations of so-called Questionable Research Practices (QRPs) — such as only reporting data that support your hypothesis — and must publicize their policies for handling (QRPs).

The Board for the Prevention of Scientific Misconduct will replace the Danish Committees on Scientific Dishonesty (DCSD).

You can read the press release from the Ministry of Higher Education and Science here. We translated it into English, here.

Continue reading Denmark to institute sweeping changes in handling misconduct

Four in 10 biomedical papers out of China are tainted by misconduct, says new survey

Chinese biomedical researchers estimate that 40% of research in their country has been affected in some way by misconduct, according to a new survey.

The authors are quick to caution against putting too much stock in this figure due to the subjective nature of the survey, published in Science and Engineering Ethics. The estimates also spanned a wide range, with a standard deviation of ±24%. But they say that the responses to this question and others on the survey suggest that scientists in the region feel academic misconduct remains a major problem that authorities have failed to adequately address. (Indeed, a recent analysis from Quartz using Retraction Watch data showed that researchers based in China publish more papers retracted for fake peer reviews than all other countries put together.)

The survey was designed by employees at Medjaden, a Hong Kong-based editing company that assists mainland Chinese biomedical researchers publishing in English-language journals. They invited all of their registered users by email to complete two surveys—roughly 10,000 users in 2010 and 15,000 in 2015. Like most online surveys, this one had a low response rate—around 5%, so caveats about sampling bias apply.

Study co-author Hua He, who is also Medjaden’s CEO, said:

Continue reading Four in 10 biomedical papers out of China are tainted by misconduct, says new survey

Journal retracts paper eight months after U.S. Feds announce findings of misconduct

In August, the U.S. Office of Research Integrity announced that a former postdoctoral fellow at the National Human Genome Research Institute (NHGRI) doctored data in two published papers.

It took one journal a little longer than five months to remove the researcher’s name from the co-author list, and replace one figure.

It took the second journal more than eight months to retract the paper.

Here’s the notice for “A BLOC-1 Mutation Screen Reveals that PLDN Is Mutated in Hermansky-Pudlak Syndrome Type 9,” published by the American Journal of Human Genetics (AJHG):

Continue reading Journal retracts paper eight months after U.S. Feds announce findings of misconduct

Former UCLA vice-chancellor loses cancer paper for image manipulation

The former vice chancellor for research at the University of California, Los Angeles, has retracted a 2012 paper after an internal investigation found evidence of image manipulation.

The journal Molecular Cancer Therapeutics received a letter about the problems with the paper from the UCLA Research Integrity Officer, and a retraction request from last author James Economou, also the chief of surgical oncology.

According to the notice, the paper duplicated images from a 2011 paper also by first author Ali Jazirehi, based at UCLA. This is Jazirehi’s second retraction.

Here’s more from the notice:

Continue reading Former UCLA vice-chancellor loses cancer paper for image manipulation

Ecologist loses appeal for whistleblower protection

A top federal U.S. court has confirmed a decision by the National Science Foundation (NSF) to deny federal whistleblower protection to an ecologist who was fired after accusing a colleague of fraud.

After initially forcing NSF to more clearly explain its decision, the Denver-based U.S. Court of Appeals for the 10th Circuit has agreed with the conclusions of NSF’s updated investigation, denying former Kansas State University researcher Joseph Craine’s appeal.

Attorney Paul Thaler, who has handled cases involving scientific misconduct (but was not involved with this one), told Retraction Watch that the latest decision appears to be the end of a cautionary tale of how not to report misconduct.

Continue reading Ecologist loses appeal for whistleblower protection

“Remarkable” it was ever accepted, says report: Science to retract study on fish and microplastics

Science is retracting a paper about how human pollution is harming fish, after months of questions about the validity of the data.

The move, first reported by the news side of Science on Friday, follows a new report from a review board in Sweden that concluded the authors were guilty of “scientific dishonesty,” and the paper should be “recalled.”

The report had some strong words for the journal and the university that conducted a preliminary investigation:

Continue reading “Remarkable” it was ever accepted, says report: Science to retract study on fish and microplastics